Bridgebio Oncology Therapeutics, Inc. (BBOT)
4.70
-0.07
(-1.47%)
USD |
NASDAQ |
Sep 21, 10:30
Bridgebio Oncology Therapeutics Price : 4.70 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 4.86 | 4.86 | 4.69 | 4.77 | 1.230M |
| Sep 17, 2026 | 4.84 | 5.10 | 4.84 | 4.89 | 417384.0 |
| Sep 16, 2026 | 4.93 | 4.99 | 4.71 | 4.76 | 855554.0 |
| Sep 15, 2026 | 5.01 | 5.015 | 4.72 | 4.88 | 629205.0 |
| Sep 14, 2026 | 4.91 | 5.18 | 4.85 | 5.05 | 956105.0 |
| Sep 11, 2026 | 5.53 | 5.616 | 4.90 | 4.95 | 1.631M |
| Sep 10, 2026 | 6.785 | 6.785 | 5.48 | 5.52 | 2.790M |
| Sep 09, 2026 | 8.86 | 8.86 | 6.295 | 6.755 | 1.500M |
| Sep 08, 2026 | 8.88 | 9.05 | 8.775 | 8.86 | 154114.0 |
| Sep 04, 2026 | 8.80 | 9.06 | 8.65 | 8.98 | 117621.0 |
| Sep 03, 2026 | 8.93 | 9.041 | 8.66 | 8.90 | 139211.0 |
| Sep 02, 2026 | 8.81 | 9.185 | 8.73 | 8.89 | 238880.0 |
| Sep 01, 2026 | 8.70 | 8.90 | 8.535 | 8.82 | 146125.0 |
| Aug 31, 2026 | 8.72 | 9.195 | 8.410 | 8.80 | 476039.0 |
| Aug 28, 2026 | 9.16 | 9.16 | 8.69 | 8.74 | 195037.0 |
| Aug 27, 2026 | 9.19 | 9.315 | 9.06 | 9.18 | 385266.0 |
| Aug 26, 2026 | 9.36 | 9.47 | 9.04 | 9.26 | 247153.0 |
| Aug 25, 2026 | 9.24 | 9.472 | 9.18 | 9.37 | 197974.0 |
| Aug 24, 2026 | 9.10 | 9.358 | 8.80 | 9.14 | 338518.0 |
| Aug 21, 2026 | 9.19 | 9.435 | 9.03 | 9.08 | 171566.0 |
| Aug 20, 2026 | 9.55 | 9.78 | 9.08 | 9.08 | 203262.0 |
| Aug 19, 2026 | 9.16 | 9.72 | 9.14 | 9.60 | 414325.0 |
| Aug 18, 2026 | 9.02 | 9.125 | 8.82 | 8.95 | 446874.0 |
| Aug 17, 2026 | 8.90 | 9.400 | 8.90 | 9.04 | 249911.0 |
| Aug 14, 2026 | 9.22 | 9.49 | 8.80 | 9.06 | 227475.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 68.18 |
| Oncolytics Biotech, Inc. | 0.7799 |
| Sangamo Therapeutics, Inc. | 0.1449 |
| Sarepta Therapeutics, Inc. | 20.42 |
| Anixa Biosciences, Inc. | 2.73 |
Price Related Metrics
| Price to Book Value | 1.165 |
| Earnings Yield | -26.23K% |
| Market Cap | 376.54M |